CRISPR Gene Editing

Cut-and-paste DNA editing. FDA-approved. Nobel Prize. We're rewriting life.

CRISPR gene editing gives humanity the ability to cut-and-paste DNA like editing a text file, a feat recognized with the 2020 Nobel Prize for Jennifer Doudna and Emmanuelle Charpentier. In 2023, the FDA approved Casgevy, the first CRISPR-based therapy, to cure sickle cell disease, marking a 100% correction rate in clinical trials for transfusion-dependent patients. The ethical implications are staggering; the medical potential is unlimited. We are literally rewriting the source code of life.

View Source

Comments on "CRISPR Gene Editing"

Have a take on this ranking?

Comments are how the argument actually happens here. Posting one needs a free account — it takes about a minute.

Create a free account Already have one? Sign in

No comments yet.

The first comment sets the terms of the argument.

Photos (1)

Comments on "CRISPR Gene Editing"